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Factors Promoting or Preventing Caregivers from Allowing Pediatric 
Participation in Research 
 
 
 
 
 
Introduction 
 
In recent years, participation in clinical research has greatly 
influenced the prevention, prognosis, and treatment of many complex 
diseases. Although study purpose, protocol, and personal incentives 
influence enrollment in clinical studies, the greatest motivators for 
participation are the advancement of knowledge and the altruistic hope of 
finding an effective medical treatment.1 Unfortunately, relatively low 
enrollment ranging from 3% to 20% has been reported for clinical trials for 
certain chronic conditions such as cancer.2  
Although awareness of the benefits of and opportunities afforded by 
clinical trials has increased in the population, this awareness is far from 
ubiquitous and reflects poor inclusion of racial/ethnic minorities, women, 
and children.3 Among racial/ethnic minorities, study designs, cultural 
differences, and linguistic barriers appear to limit participation, whereas the 
opportunity for medical treatment seems to increase willingness to engage 
in clinical studies.2,4 Assuming that minorities will not participate in a clinical 
study has been shown to be a barrier for recruitment that lessens 
participation and representation of underserved individuals in clinical 
research.5,6 Pediatric clinical research has improved during recent years, 
giving equal importance to common and uncommon diseases, designing 
studies to address potential differences across a spectrum of ages, and 
requiring participants’ assent and parental consent.7 The likelihood of a 
child participating in a clinical trial is mostly independent of the child’s 
willingness to participate; children’s lack of autonomy obliges parental 
involvement, which is concurrently conditional to parental understanding, 
trust, and endorsement of the research study. Given the trajectory of 
children’s health into adulthood and the need to improve the health of the 
next generation, pediatric inclusion in the development of evidence-based 
medicine and therapies is paramount. From this perspective, this study 
identified potential predictors for allowing children to participate in clinical 
studies and evaluated whether motivators that promote or prevent parental 
support of children’s participation differed according to racial/ethnic 
categorization. 
1
Fernández et al.: Factors influencing children’s participation in research
Published by DigitalCommons@TMC, 2020
 
Methods 
 
Study Design and Participants 
  
A sample of residents in South Florida’s Miami-Dade, Broward, and 
Palm Beach counties was surveyed via landline or cell phone by 
Professional Research Consultants Inc. (PRC). For the telephone-
administered survey, PRC assigned a caller ID number that was local to the 
area, made multiple attempts to reach respondents, and called at different 
times of the day on different days of the week. The sample was stratified by 
county to ensure adequate representation among all strata. At the time of 
the interview, for households with multiple children age 0–18, one child was 
selected at random based on which had the most recent birthday, and the 
survey questions were asked about that specific child. This produced a 
sample that is more representative by demographics of age and gender. 
The survey respondents were adults age 18 and older who had at least 1 
child residing in the household for whom the respondent was the health care 
decision-maker (child’s caregiver).  
A sample of 1057 caregivers (the complete sample of the Community 
Health Needs Assessment, CHNA) were included in the study, and 
participants self-identified as Non-Hispanic White (n=406), Non-Hispanic 
Black (n=177), Hispanic (n=398), Non-Hispanic Asian (n=30), and others 
(n=18). Caregivers were 27.1% male (n=284) and 72.9% female (n=764). 
Data were de-identified prior to the investigator receiving the data, and an 
Institutional Review Board-exempt research protocol was approved for this 
study. 
 
Survey Methods 
 
The survey interview was constructed as part of a broader CHNA 
effort by a range of community stakeholders in child health in the South 
Florida region, including health care systems, city departments, health 
insurance companies, and school districts. For this research, we conducted 
a secondary analysis of CHNA data. Survey questions pertained to health 
care access, health insurance, chronic conditions, care utilization, 
demographics of the child of interest, and demographics of the respondent. 
To preserve generalizability of the responses, terms such as “clinical trial” 
were defined during the administration of the questionnaire. After 
nonresponse weights were taken into account, the data were post-stratified 
based on sample characteristics of age, gender, race, ethnicity, and poverty 
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status to further align the survey responses to known proportions in the 
population using U.S. Census Bureau population estimates. A statistical 
application package applied weighting variables that produced a sample. 
While the integrity of each individual’s responses is maintained, 1 
respondent’s responses may contribute to the whole the same weight as, 
for example, 1.1 respondents. Another respondent, whose demographic 
characteristics may have been slightly oversampled, may contribute the 
same weight as 0.9 respondents. 
 
Outcomes of Interest 
 
Participants were asked, “In general, how likely would you be to allow 
your child to participate in a clinical research trial?” with the answer options 
being “Not at All Likely,” “Somewhat Likely,” or “Very Likely.” This question 
was followed by either, “What is the MAIN reason you would allow your child 
to participate in a clinical research trial?” or “What is the main reason you 
would NOT allow your child to participate in a clinical research trial?” These 
questions were open ended, meaning that respondents were free to say 
whatever came to mind, and their verbatim responses were recorded. 
These responses were then grouped thematically for the analysis. For those 
not allowing participation, responses were classified into: “Fear or concern 
over study,” “Need more information to decide,” “Inconvenience,” “Potential 
lack of health benefit,” “Other,” or “Don’t know/Not sure.” For those allowing 
participation, responses were classified as “Current health,” “Future health,” 
“Science,” “Other,” or “Unsure.” These classifications were used to 
understand the motivators that promote or prevent allowing participation, 
whereas data from the other survey questions were used to identify 
predictors for allowing participation. 
 
Analytic Approach 
 
Initial data preparation required the evaluation of item-level 
nonresponse that, although limited for any one variable, could have been 
more substantial in multivariate models. A machine learning approach to 
variable multiple imputation was used to address item-level nonresponse 
utilizing random forest imputation8,9. This approach accommodates the wide 
number of potential interactions among covariates that may explain item-
level nonresponse. Descriptive statistics were obtained for demographic 
variables through percentages and 95% confidence intervals (CI).10 
Unweighted and weighted responses for the question regarding the 
willingness of participation in a clinical research trial and reasons to 
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participate or not also were described in percentages and 95% CI for the 
weighted estimates. We also evaluated whether reasons for allowing and 
not allowing participation varied by race using weighted chi-square 
analyses. 
Preliminary identification of predictors for pediatric research 
participation in clinical trials was achieved by performing exploratory 
unadjusted weighted multinomial association tests between the outcome of 
interest and a range of possibly related factors from the survey that may 
have influenced participation. An associated group of predictors were 
identified based on statistical associations at p < .10 and/or based on 
theoretical relevance. These predictors included the child’s age, sex, 
race/ethnicity categorization, insurance status, survey items capturing 
whether the child had difficulties accessing health care, whether the child 
was reported to be limited in ability to engage in normal activities due to any 
condition, survey items capturing whether the child has ever had a chronic 
condition, whether the child has ever needed a specialist, whether the child 
needed special therapy or medication for any condition, the child’s weight 
status (underweight, normal weight, overweight), household’s poverty 
status, household language most predominantly used, and respondent’s 
education level. Body mass index (BMI) was used to assess weight status, 
and the BMI number was plotted on the CDC BMI-for-age growth charts to 
obtain a percentile ranking. Percentiles were used to classify the weight 
status as: underweight <5th percentile, healthy weight 5th and <85th 
percentile, overweight 85th and <95th percentile, and obese 95th 
percentile. 
Preliminarily identified predictors were incorporated into a weighted 
multivariable multinomial logistic model (full model). Rather than including 
all identified covariates capturing information about access to care and 
child’s health, 2 continuous sum score variables were derived. A “difficulties 
in access to care” score was constructed by summing difficulties 
experienced in the past 12 months (1=Yes, 0=No) among (a) difficulty 
finding a physician to care for the child, (b) difficulty finding an appointment 
for care, (c) difficulty finding available hours for care, (d) difficulty finding 
transportation for care, (e) difficulty paying for the cost of care, and (f) 
difficulty in the cost of medications. The reported chronic conditions sum 
score was constructed by summing the respondents’ reports that the child 
had ever suffered from or been diagnosed with the following: (a) food 
allergies, (b) skin allergies, (c) respiratory allergies, (d) asthma, (e) a brain 
injury or concussion, (f) diabetes, (g) 3 or more ear infections, (h) epilepsy, 
(i) eye problems that could not be corrected with glasses or contact lenses, 
(j) hearing problems, (k) a learning disability, or (l) a migraine.  
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Because of the limits in sample size, the covariates included in the 
full model were further restricted into a reduced multivariable multinomial 
model containing only those that showed evidence of a statistically marginal 
or lower p-value (p < .10). All statistical analyses were performed using R 
3.3 software. 
 
Results 
 
Table 1 shows weighted proportions and 95% CI for background 
demographic variables. Table 2 provides unweighted and weighted 
percentages according to how likely respondents were to allow a child to 
participate in a clinical research trial. About 2% of participants (n=18) 
reported they were unsure about participation or refused to provide an 
answer to the question. These responses were considered missing and 
imputed in weighted analyses to limit covariate categories with small 
frequencies included in models. Unweighted proportions were within the 
95% CI of weighted proportions, suggesting limited extreme changes during 
sample weighting adjustments.  
Table 3 shows unweighted and weighted descriptive information 
about reasons that caregivers reported would influence their decision to 
allow their children to participate in clinical research. Among the responders 
who were very likely to allow their child to participate in research, the 
majority chose “other” as their reason for participation, particularly if their 
child was in excellent health. Some of the reasons categorized by “other” 
were: “don’t know/not sure,” “purpose of research,” “money,” “safety,” “if 
child would want to do it,” “depends on how it is done,” “availability of new 
medications,” and “if appropriate for age.” The most common responses for 
the selection “other” included “believe it is a good idea” and “depends on 
the purpose of the research.” For responders who were unlikely to allow 
their child to participate in clinical research, the most common response 
was “fear/concern over study,” while the least likely reason was 
“inconvenience.” The classification “fear/concern over study” included 
specific responses such as “unknown side effects,” “no trust,” “child is too 
young,” “unethical,” “painful,” “not FDA approved,” “unhealthy,” and “not 
going to use my child as guinea pig.” Specific responses grouped under 
“inconvenience” included “scheduling” and “lack of time.” Weighted chi-
squared analyses show no differences by race/ethnicity for the reasons to 
allow participation [χ² (12) = 16.82, p=.41] or reasons not to allow 
participation [ χ² (15) = 25.39, p=.19].  
To identify potential predictors for allowing participation, the 
significant predictors of the full model were retained in a final reduced 
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multivariable multinomial model that fit the data more parsimoniously than 
the full exploratory model (AICReduced=1,913.35 vs. AICFull=1,941.39; 
BICReduced=2,002.68 vs. BICFull=2,199.47).  
The independent variables in the reduced model included the child’s 
race/ethnicity, the respondent’s sex, whether the child was reported to be 
limited in ability to engage in normal activities due to any condition, child’s 
weight, and the difficulties in accessing health care sum score. All results 
for the multinomial models are reported based on the reduced model.   
Weighted odds ratios and 95% CIs of the contributions of the 
predictors from the reduced multivariate multinomial model to the 
willingness to participate in clinical research are represented in Figure 1. 
Using Non-Hispanic White (NHW) caregivers as the reference group, there 
were no differences in the likelihood to allow participation among Hispanic 
caregivers. Interestingly, in Non-Hispanic Black (NHB) caregivers, there 
was a statistical difference between “very likely” to allow participation 
relative to “somewhat likely” when compared with NHW caregivers. In 
respondents classified as another race/ethnicity, there was a statistical 
difference between “somewhat likely” to allow participation relative to 
“unlikely.” Overall, males appeared to be more likely to allow participation 
than females. “Child health care access difficulties” in the past 12 months 
were consistently associated with a response of being “very likely” to allow 
participation and “somewhat likely” to allow participation. Similarly, “child’s 
limited ability to do things due to a health condition” was associated with 
“very likely” and “somewhat likely” responses to allow participation. In 
general, respondents who reported that their child was underweight (vs. 
normal weight status) were more likely to allow clinical trial participation, 
whereas respondents of children who were overweight relative to normal 
weight did not differ in likelihood of allowing participation. 
Figure 2 shows adjusted marginal probability estimates for the 
variables in the reduced final multinomial model. Even when adjusting for 
other factors, the marginal probability for most predictors was highest for 
being “Not at all likely” to allow participation (0.32 to 0.60). In contrast, 
across all predictors, the lowest adjusted probability was observed among 
the “Very likely to allow participation” respondents (0.07 to 0.23). 
Noteworthy is the observation that those respondents who reported their 
child had a health condition that limited the child’s ability were also 
respondents who had a higher adjusted marginal probability of saying that 
they would be “Somewhat likely to allow participation” (0.42), which is higher 
than the adjusted marginal probability for being “Not at all likely” to allow 
participation (0.32) if the child had a health condition. In addition, the 
number of health care access difficulties reported by caregivers was related 
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to the likelihood of participation (Figure 3). The higher the number of health 
care access difficulties reported, the more likely the caregiver was to allow 
participation in clinical research.  
 
Discussion 
 
This study was designed to explore the role of different factors in 
promoting participation or preventing caregivers from allowing children to 
participate in clinical studies and to identify potential predictors for the 
willingness to participate. The results show that there are different reasons 
why caregivers will allow or reject their child’s participation in clinical 
research, which include the sex of the participant, access to health care, 
race of the responder, and child’s weight status. Our findings reflect the 
complex etiology underlying the participation of children in clinical research. 
Aspects related to the design of the study, cultural differences, and 
linguistic barriers have been shown to limit participation of minorities in 
clinical investigations.2 Our results suggest that the factors and motivators 
influencing caregiver decisions about allowing their child to participate in 
clinical research differ according to race/ethnic classification. NHB 
caregivers were more receptive to allowing participation, an observation 
contrary to previous reports of minorities’ lack of willingness to participate 
in clinical research opportunities but in line with reports of minorities willing 
to but not asked to participate.5,11,12 Although minority participation in clinical 
trials is complex, increased receptivity for participation may be a 
consequence of recent initiatives targeted to create awareness of the need 
for community networks to improve minority health, potentially combined 
with the altruistic commitment of minorities to find medical treatment for their 
communities.13,14 From this perspective, recruitment efforts to increase 
minority participation might need to be strategically marketed as 
educational campaigns to create awareness of health as a social and 
collective responsibility.  
There appears to be a gender disparity regarding caregivers’ 
willingness to allow their child to participate in clinical research. Male 
caregivers are more likely to allow participation (15%) compared to female 
caregivers (7%). The weight status of the child also appears to influence 
willingness to participate. Interestingly, probability estimates showed a 
greater disposition toward research participation among caregivers of 
children with underweight status and a greater aversion to participation 
among caregivers of children perceived to be within normal weight. 
Our data indicate that respondents whose child had a health 
condition that limited his/her ability were more willing to participate in 
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research and less willing to refuse participation. Also, the adjusted marginal 
probability of those who are very or somewhat likely to participate increases 
as the number of health care access difficulties increases (Figure 3). 
Although research has shown that exposure to medical treatment or having 
the disease addressed by a clinical trial increases participation, our data 
suggest that parents might view a clinical study as a health care treatment 
option.4,15 Parents tend to weigh risks and benefits when considering 
children’s participation in clinical research and are motivated by the 
opportunity to access new treatments, healthcare professionals, and health 
information.16 However, the observation that pediatric research participation 
is influenced by the health of the child raises concerns about the 
generalizability of the results of that research when health-biased samples 
are used to provide overall recommendations to the pediatric population. 
It is noteworthy that no differences were observed in the motivators 
for clinical research participation between NHW and Hispanics. This finding 
is inconsistent with national estimates of Hispanic participation in clinical 
trials.17,18 A potential explanation for this discrepancy may be related to 
regional variation of social structures and the role Hispanics play in the local 
communities.19 In Miami-Dade County, Hispanics make up close to 70% of 
the population and are widely integrated into the social, political, and cultural 
fabric of the community. It is possible that this local environment contributes 
to the similarities noted between the responses of NHW and Hispanics in 
this study. These findings might inform future strategies directed toward 
reducing the gap in clinical research representation of minority populations, 
such as creating awareness among communities and considering health 
care access, race of the responder, and other variables. In addition, our 
findings underscore the need for future studies that account for the 
socioeconomic, political, and cultural diversity of Hispanic and other 
minority populations.  
As in any population study, some limitations must be recognized. 
Foremost, the data utilized for this study was based on a survey whose 
original purpose was not directed toward understanding clinical research 
participation willingness, and the questions utilized in this survey were not 
designed to be used as a research tool for such. Consequently, the creation 
of categories capturing those potential motivators influencing clinical 
research was arbitrary and relied on the creativity, clinical experience, and 
consensual integrity of the investigators. The benefits of having a 
representative sample of the population of Miami-Dade, Broward, and Palm 
Beach counties were also clouded by the limitations of a sample size that 
became diluted when categorized by reasons for participation and 
racial/ethnic categories. The limited sample size, combined with the 
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laborious statistical approach, impaired the evaluation of potential 
interactions between and among predictors, including relationships 
between poverty levels and racial/ethnic categories. As a result, the 
exploration of such interactive terms was not included in the analyses. Even 
though this sample is representative, the self-selection of the caregivers to 
participate may limit the participation of those who are distrustful of research 
and who, in turn, are unlikely to allow their child to participate in a clinical 
trial. It is most important to state that, despite the limitations in the 
experimental design of the study, the importance of the results of this 
investigation cannot be minimized, particularly when understanding the 
need to increase pediatric participation in clinical research. The 
thoroughness of our statistical methodology and overall scientific approach 
to address our objective serve as evidence of the scientific rigor of our 
research team and our commitment to improve public health initiatives that 
can be inclusive of all.    
From the perspective that clinically applied research will inform and 
improve health outcomes for all segments of the population, our findings 
raise awareness of the complex and multifactorial nature of engaging 
children of diverse backgrounds in clinical research participation and of the 
challenges faced by public health initiatives when trying to translate 
research findings into policies and treatments that might fail to be applicable 
to all.20 Further research into the development of strategies for participatory 
research engagement of all sectors of the population seems paramount in 
order to implement preventive and treatment strategies that are culturally 
and biologically sensitive, fair, and equitable to all segments of the pediatric 
population. 
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Table 1. Survey weighted estimates of background demographic 
characteristics of children in a sample of residents in South Florida, 2015. 
 
Variable Level N* Proportion (95% CI) 
Child age (y) 4/Under 352 33.33% (29.79% - 36.87%) 
 5 to 12 409 38.72% (35.42% - 42.02%) 
 13 to 17 295 27.94% (25.08% - 30.80%) 
Child sex Male 540 51.13% (47.67% - 54.59%) 
 Female 516 48.87% (45.41% - 52.33%) 
Child 
Race/ethnicity 
Non-Hispanic White (NHW) 286 27.08% (24.44% - 29.72%) 
 Hispanic 445 42.18% (38.74% - 45.62%) 
 Non-Hispanic Black (NHB) 253 23.98% (20.69% - 27.27%) 
 Other race/ethnicity 71 6.76% (4.94% - 8.58%) 
Child insurance 
status 
Private health insurance 496 46.95% (43.55% - 50.35%) 
 Medicaid or Medicare 396 37.49% (33.92% - 41.06%) 
 Uninsured 85 8.05% (6.08% - 10.02%) 
 Other 79 7.50% (5.59% - 9.41%) 
Child has usual 
source of care 
Yes 869 82.28% (79.49% - 85.07%) 
 No 187 17.72% (14.93% - 20.51%) 
HHS poverty status 200% of poverty or higher 600 56.77% (53.16% - 60.38%) 
 100% to 199% of poverty 238 22.56% (19.69% - 25.43%) 
 Below poverty 218 20.67% (17.00% - 24.34%) 
Household 
language 
English 855 80.90% (78.01% - 83.79%) 
 Spanish 140 13.25% (10.69% - 15.81%) 
 Other 61 5.85% (4.19% - 7.51%) 
Caregiver 
education level 
Postgraduate 184 17.43% (15.11% - 19.75%) 
 College graduate 323 30.59% (27.54% - 33.64%) 
 Some college/technical 
school 
347 32.88% (29.53% - 36.23%) 
 High school or less 201 19.10% (16.08% - 22.12%) 
Child’s weight 
status 
About the right weight 767 72.61% (69.52% - 75.70%) 
 Overweight 147 13.98% (11.60% - 16.36%) 
  Underweight 141 13.41% (11.03% - 15.79%) 
 *N values are based on the rounded weighted estimates after imputation  
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Table 2. Responses to the question “In general, how likely would you be to 
allow your child to participate in a clinical research trial?” Answers are 
provided for unweighted and weighted estimates in a sample of residents in 
South Florida, 2015. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 
Unweighted Weighted 
N Percent N Percent (CI) 
Not at All 
Likely 
584 55.25% 570 53.94% (50.47% - 57.41%) 
Somewhat 
Likely 
350 33.11% 367 34.73% (31.41% - 38.05%) 
Very Likely 105 9.93% 119 11.32% (9.02% - 13.62%) 
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Table 3. Unweighted and weighted percent estimates of identified reasons 
to participate or not participate among respondents in a sample of residents 
in South Florida, 2015. 
 
 
Level 
Unweighted Weighted 
N Percent N Percent 
R
e
a
s
o
n
s
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t 
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Fear or concern over 
study 
477 51.40% 466 50.84% (47.15% - 
54.54%) 
Need more information 
to decide 
139 14.98% 128 13.93% (11.51% - 
16.36%) 
Inconvenience 50 5.39% 43 4.69% (3.20% - 6.18%) 
Potential lack of health 
benefit 
56 6.03% 54 5.87% (4.19% - 7.56%) 
Other 106 11.42% 111 12.03% (9.57% - 14.49%) 
Don’t know/Not sure 100 10.78% 116 12.63% (9.96% - 15.29%) 
R
e
a
s
o
n
s
 t
o
 
P
a
rt
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a
te
 
Child current health 88 11.13% 88 10.87% (8.45% - 13.29%) 
Child future health 52 6.57% 51 6.30% (4.41% - 8.18%) 
Science 157 19.85% 146 18.10% (15.13% - 
21.06%) 
Other 404 51.07% 408 50.60% (46.59% - 
54.60%) 
Unsure 90 11.38% 115 14.14% (11.04% - 
17.23%) 
 
  
14
Journal of Applied Research on Children:  Informing Policy for Children at Risk, Vol. 11 [2020], Iss. 1, Art. 6
https://digitalcommons.library.tmc.edu/childrenatrisk/vol11/iss1/6
Figure 1. Multinomial model estimates according to race/ethnicity, sex, 
child limited ability due to health condition, and child weight status in a 
sample of residents in South Florida, 2015. 
 
 
Multinomial odds ratios (circles) and 95% CIs (black error bars) show the magnitude of 
effects of each covariate in the final model. 95% CI bars that do not cross the red line at 
1.00 can quickly be identified as statistically significant. The OR and associated 95% CI for 
each multinomial outcome contrast are also listed to the right of the visual effects.  
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Figure 2. Adjusted marginal probability estimates and 95% CI according to 
child’s race/ethnicity, sex, limited ability due to health condition, and weight 
status in a sample of residents in South Florida, 2015. 
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Figure 3. Health care access difficulties and participation in a sample of 
residents in South Florida, 2015. 
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